SEER-based hypothesis-generating research for minimum lymph node evaluation in early-stage pancreatic ductal adenocarcinoma patients
The minimum threshold for optimal survival of stage I or II IDCP patients in ELNs ≥10 and ELN/RNP ratio = 9, which is more appropriate for stage II IDCP patients. The optimal threshold of survival benefit for T3N1M0 patients is ELNs >12, with ELNs >7 for T3N0M0 patients.
Authors
- Heng Xu (ORCID: https://orcid.org/0000-0002-3717-0412)
- Ting Ge
- Guangrui Huang (ORCID: https://orcid.org/0000-0003-1846-0227)
- Yujie Wang (ORCID: https://orcid.org/0000-0002-7476-0542)
- Hesong Wang (ORCID: https://orcid.org/0000-0003-1920-4700)
- Aimin Yan
- Ruhang Li
- Huaijuan Huang
- Enfan Xiao
Institutions
- Beijing University of Chinese Medicine (CN)
- Beihang University (CN)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-11-07
- DOI
- https://doi.org/10.3389/fsurg.2025.1605726
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00